ACC urges COVID-19 vaccine prioritization for highest risk heart disease patients
Health policy statement recommends priority vaccination for specific heart disease patient populations not specified in CDC distribution guidance
2021-02-12
(Press-News.org) COVID-19 vaccine prioritization should prioritize those with advanced cardiovascular (CVD) disease over well-managed CVD disease, according to an American College of Cardiology (ACC) health policy statement published in the Journal of the American College of Cardiology (JACC). All CVD patients face a higher risk of COVID-19 complications and should receive the vaccine quickly, but recommendations in this paper serve to guide clinicians in prioritizing their most vulnerable patients within the larger CVD group, while considering disparities in COVID-19 outcomes among different racial/ethnic groups and socioeconomic levels.
"A coherent vaccine allocation strategy will consider the exposure risks and clinical risks of given individuals and populations," said Thomas M. Maddox, MD MSc, professor of cardiology at Washington University School of Medicine in St. Louis and co-chair of the health policy statement. "In addition, it will take into account those demographic populations that, for a variety of reasons, have additional risks that lead to higher rates of COVID-19 infection and severe health outcomes."
As of January 2021, there were almost 99 million COVID-19 cases and over 2 million deaths caused by the coronavirus worldwide. With the quick development of multiple vaccines, the Centers for Disease Control and Prevention (CDC) issued phased recommendations for which populations should get vaccinated first. Under Phase 1c of the CDC guidance, all patients from 16-64 years old with medical conditions that increase the risk for severe COVID-19 infection should receive the vaccine. Although the guidance states that heart conditions, hypertension, diabetes, obesity and smoking are examples of such high-risk medical conditions, it was silent on varying levels of risk among the variety of CVD conditions that cardiovascular clinicians manage.
In response, the writing group developed a policy statement that provides overall considerations of both exposure and clinical risk needed for vaccine allocation efforts. It presents the specific evidence and risk considerations related to CVD and COVID-19, and proposes a tiered schema of CVD risk to incorporate into vaccine allocation decisions. In addition, this policy statement highlights the large disparities in COVID-19 and CVD outcomes among racial and ethnic groups and different socioeconomic status levels and calls for consideration of these disparities in allocation decisions.
"Our proposed vaccine allocation schema outlines key CVD clinical risk considerations within the broader context of key overall risk considerations including exposure, disparities, health care access, advanced age and multimorbidity," Maddox said. "Patients' risk categorization is determined by highest tier in which meet one or more of its criteria."
Some examples in the proposed vaccine allocation schema include patients with poorly controlled hypertension, insulin-dependent diabetes or diabetes with microvascular and/or macrovascular complications as a result of poor glycemic control should be considered higher risk compared to patients who are medically optimized. Similarly, patients with morbid obesity should be considered higher risk compared to patients who are overweight.
Patients with severe medical conditions, such as advanced CVD, may require long-term stays in nursing homes or rehabilitation centers, which increases their risk of COVID-19 exposure. Data shows that the clinical risk for severe COVID-19 infection is associated with both advanced age and preexisting medical conditions, especially when two or more co-occur. In addition to multimorbidity, data has found adverse effects of frailty in patients with COVID-19. The CDC's phased vaccine allocation recommendations prioritize patients with advanced age, which is in accordance with the CVD-related risk associated with advanced age. However, this policy statement urges older patients with multiple comorbidities, including CVD conditions and/or frailty should be prioritized for COVID-19 vaccination.
"We hope that this document can be used to guide COVID-19 vaccine allocation and patient outreach in the context of prolonged demand-supply mismatch as we enter Phase 1c," Maddox said.
INFORMATION:
The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its 54,000 members is to transform cardiovascular care and to improve heart health. The ACC bestows credentials upon cardiovascular professionals who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. The College also provides professional medical education, disseminates cardiovascular research through its world-renowned JACC Journals, operates national registries to measure and improve care, and offers cardiovascular accreditation to hospitals and institutions. For more, visit END
ELSE PRESS RELEASES FROM THIS DATE:
2021-02-12
A new type of drug that helps target chemotherapy directly to cancer cells has been found to significantly increase survival of patients with the most common form of bladder cancer, according to results from a phase III clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust.
The results are published in the New England Journal of Medicine and were presented at the 2021 American Society of Clinical Oncology's Genitourinary Cancers Symposium.
Urothelial cancer is the most common type of bladder cancer (90 percent of cases) and can also be found in the renal pelvis (where urine collects inside the kidney), ureter (tube that connects the kidneys ...
2021-02-12
WORCESTER, Mass. -- New research by Christopher A. Williams, an environmental scientist and professor in Clark University's Graduate School of Geography, reveals that deforestation in the U.S. does not always cause planetary warming, as is commonly assumed; instead, in some places, it actually cools the planet. A peer-reviewed study by Williams and his team, "Climate Impacts of U.S. Forest Loss Span Net Warming to Net Cooling," published today (Feb. 12) in Science Advances. The team's discovery has important implications for policy and management efforts that are turning to forests to mitigate climate change.
It ...
2021-02-12
RIVERSIDE, Calif. -- Astrocytes -- star-shaped cells in the brain that are actively involved in brain function -- may play an important role in stuttering, a study led by a University of California, Riverside, expert on stuttering has found.
"Our study suggests that treatment with the medication risperidone leads to increased activity of the striatum in persons who stutter," said Dr. END ...
2021-02-12
HANOVER, N.H. - February 12, 2021 - A newly discovered planetary system will provide researchers with the rare chance to study a group of growing planets, according to research co-led by Dartmouth.
The new system, named TOI 451, is made up of at least three neighboring planets that orbit the same sun. The planets range in size between that of Earth and Neptune.
According to the research team, NASA's Hubble Space Telescope and its planned successor, the James Webb Space Telescope, can be used to study the atmosphere of each planet. Such research could lead to information on how planetary systems like our own solar system evolve.
"The sun in this planetary system is very similar to our own sun, but much younger," ...
2021-02-12
In your quest for true love and that elusive happily ever after, are you waiting for the "right" person to come along, or do you find yourself going for the cutest guy or girl in the room, hoping things will work out? Do you leave your options open, hoping to "trade-up" at the next opportunity, or do you invest in your relationship with an eye on the cost-benefits analysis?
For something so fundamental to our existence, mate selection remains one of humanity's most enduring mysteries. It's been the topic of intense psychological research for decades, spawning myriad hypotheses of why we choose whom we choose.
"Mate choice is really complicated, especially in humans," ...
2021-02-12
CHICAGO (February 12, 2021): Since 2010, National Institutes of Health (NIH) funding to support surgeon scientists has, remarkably, risen significantly while funding to support other non-surgeon physicians has significantly decreased. This growth has occurred despite an overall decrease in NIH funding and an increase in demand for clinical productivity. These findings are according to an " END ...
2021-02-12
Scientists at Lund University have discovered how E. coli bacteria target and degrade the well-known oncogene MYC, which is involved in many forms of cancer. The study is now published in Nature Biotechnology.
Cancer cells grow too fast, outcompete normal cells and spread to distant sites, where they cause metastases. Understanding what makes cancer cells so efficient and threatening is critically important and stopping them has always been the goal of cancer research. Early studies identified so-called ''oncogenes''; genes that that normally control cell growth but when mutated may be responsible for the creation of cancer cells and explain their competitive advantage.
The pleiotropic transcription factor MYC has been ...
2021-02-12
(BOSTON) -- Many life-threatening medical conditions, such as sepsis, which is triggered by blood-borne pathogens, cannot be detected accurately and quickly enough to initiate the right course of treatment. In patients that have been infected by an unknown pathogen and progress to overt sepsis, every additional hour that an effective antibiotic cannot be administered significantly increases the mortality rate, so time is of utmost essence.
The challenge with rapidly diagnosing sepsis stems from the fact that measuring only one biomarker often does not allow a clear-cut diagnosis. Engineers have struggled for decades to simultaneously quantify multiple biomarkers in whole blood with high ...
2021-02-12
The drug thalidomide was sold as a sedative under the trade name Contergan in the 1950s and 1960s. At the time, its side-effects triggered one of the largest pharmaceutical scandals in history: The medication was taken from the market after it became known that the use of Contergan during pregnancy had resulted in over 10,000 cases of severe birth defects.
Currently, the successor preparations lenalidomide and pomalidomide are prescribed under strict supervision by experienced oncologists - the active ingredients are a cornerstone of modern cancer therapies. The use of lenalidomide and pomalidomide has considerably improved the success ...
2021-02-12
EL PASO, Texas - Science is a step closer to a new response to obesity, thanks in part to a study conducted by a team that included Sergio Iñiguez, Ph.D., associate professor of psychology at The University of Texas at El Paso.
The 10-member team led by Brandon Warren, Ph.D., assistant professor of pharmacodynamics at the University of Florida, made discoveries about a specific area of the brain tied to recollection and the desire to seek and consume food. It could lead to a way to inhibit the desire to overeat.
Iñiguez, who directs UTEP's Iñiguez Behavioral Neuroscience Lab and helped design novel experimental techniques for the research, said that people tend to overeat when exposed to cues or environments that remind them of treats, which is one reason ...
LAST 30 PRESS RELEASES:
[Press-News.org] ACC urges COVID-19 vaccine prioritization for highest risk heart disease patients
Health policy statement recommends priority vaccination for specific heart disease patient populations not specified in CDC distribution guidance
